201 related articles for article (PubMed ID: 33651124)
1. Rectal MRI after neoadjuvant chemoradiation therapy: a pictorial guide to interpretation.
Almeida RR; Souza D; Matalon SA; Hornick JL; Lee LK; Silverman SG
Abdom Radiol (NY); 2021 Jul; 46(7):3044-3057. PubMed ID: 33651124
[TBL] [Abstract][Full Text] [Related]
2. Poor response at restaging MRI and high incomplete resection rates of locally advanced mucinous rectal cancer after chemoradiation therapy.
Koëter T; Stijns RCH; van Koeverden S; Hugen N; van der Heijden JAG; Nederend J; van Zwam PH; Nagtegaal ID; Verheij M; Rutten HJT; de Wilt JHW
Colorectal Dis; 2021 Sep; 23(9):2341-2347. PubMed ID: 34051043
[TBL] [Abstract][Full Text] [Related]
3. Mucinous rectal cancer: concepts and imaging challenges.
Horvat N; Hope TA; Pickhardt PJ; Petkovska I
Abdom Radiol (NY); 2019 Nov; 44(11):3569-3580. PubMed ID: 30993392
[TBL] [Abstract][Full Text] [Related]
4. Multimodal Assessments Are Needed for Restaging after Neoadjunvant Chemoradiation Therapy in Rectal Cancer Patients.
Kye BH; Kim HJ; Kim G; Kim JG; Cho HM
Cancer Res Treat; 2016 Apr; 48(2):561-6. PubMed ID: 26323642
[TBL] [Abstract][Full Text] [Related]
5. MRI for Rectal Cancer Primary Staging and Restaging After Neoadjuvant Chemoradiation Therapy: How to Do It During Daily Clinical Practice.
Cianci R; Cristel G; Agostini A; Ambrosini R; Calistri L; Petralia G; Colagrande S
Eur J Radiol; 2020 Oct; 131():109238. PubMed ID: 32905955
[TBL] [Abstract][Full Text] [Related]
6. Mucinous Degeneration on MRI After Neoadjuvant Therapy in Patients With Rectal Adenocarcinoma: Frequency and Association With Clinical Outcomes.
Miranda J; Pinto PVA; Kinochita F; Garcia CM; El Homsi M; Vilela de Oliveira C; Pandini RV; Nahas CSR; Nahas SC; Gollub MJ; Horvat N
AJR Am J Roentgenol; 2023 Aug; 221(2):206-216. PubMed ID: 36919880
[No Abstract] [Full Text] [Related]
7. [Application of magnetic resonance in "non-operative treatment" strategy for rectal cancer].
Wang Y; Chen G
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jun; 20(6):630-634. PubMed ID: 28643307
[TBL] [Abstract][Full Text] [Related]
8. MRI Evaluation of the Response of Rectal Cancer to Neoadjuvant Chemoradiation Therapy.
Kalisz KR; Enzerra MD; Paspulati RM
Radiographics; 2019; 39(2):538-556. PubMed ID: 30844347
[TBL] [Abstract][Full Text] [Related]
9. MRI assessment of rectal cancer response to neoadjuvant therapy: a multireader study.
Yuval JB; Patil S; Gangai N; Omer DM; Akselrod DG; Fung A; Harmath CB; Kampalath R; Krehbiel K; Lee S; Liu PS; Millet JD; O'Malley RB; Purysko AS; Veniero JC; Wasnik AP; Garcia-Aguilar J; Gollub MJ
Eur Radiol; 2023 Aug; 33(8):5761-5768. PubMed ID: 36814032
[TBL] [Abstract][Full Text] [Related]
10. Rectal MRI Interpretation After Neoadjuvant Therapy.
Horvat N; El Homsi M; Miranda J; Mazaheri Y; Gollub MJ; Paroder V
J Magn Reson Imaging; 2023 Feb; 57(2):353-369. PubMed ID: 36073323
[TBL] [Abstract][Full Text] [Related]
11. Rectal cancer: mucinous carcinoma on magnetic resonance imaging indicates poor response to neoadjuvant chemoradiation.
Oberholzer K; Menig M; Kreft A; Schneider A; Junginger T; Heintz A; Kreitner KF; Hötker AM; Hansen T; Düber C; Schmidberger H
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):842-8. PubMed ID: 21236593
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of progression-free survival for locally advanced rectal cancer by MRI after neoadjuvant chemoradiotherapy and total mesorectal excision].
Zhang JX; Yang Z; Fan P; Zhang JJ; Xin L; Hou LN; Du XS; Yang XT
Zhonghua Zhong Liu Za Zhi; 2018 Feb; 40(2):121-126. PubMed ID: 29502372
[No Abstract] [Full Text] [Related]
13. MRI Assessment of Complete Response to Preoperative Chemoradiation Therapy for Rectal Cancer: 2020 Guide for Practice from the Korean Society of Abdominal Radiology.
Park SH; Cho SH; Choi SH; Jang JK; Kim MJ; Kim SH; Lim JS; Moon SK; Park JH; Seo N;
Korean J Radiol; 2020 Jul; 21(7):812-828. PubMed ID: 32524782
[TBL] [Abstract][Full Text] [Related]
14. Split scar sign to predict complete response in rectal cancer after neoadjuvant chemoradiotherapy: systematic review and meta-analysis.
Torri GB; Wiethan CP; Langer FW; de Oliveira GS; Meirelles AVB; Horvat N; Tse JR; Dias AB; Altmayer S
Eur Radiol; 2024 Jun; 34(6):3874-3881. PubMed ID: 37979009
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic performance of magnetic resonance to assess treatment response after neoadjuvant therapy in patients with locally advanced rectal cancer.
Nahas SC; Nahas CSR; Cama GM; de Azambuja RL; Horvat N; Marques CFS; Menezes MR; Junior UR; Cecconello I
Abdom Radiol (NY); 2019 Nov; 44(11):3632-3640. PubMed ID: 30663025
[TBL] [Abstract][Full Text] [Related]
16. Relative Value of Restaging MRI, CT, and FDG-PET Scan After Preoperative Chemoradiation for Rectal Cancer.
Schneider DA; Akhurst TJ; Ngan SY; Warrier SK; Michael M; Lynch AC; Te Marvelde L; Heriot AG
Dis Colon Rectum; 2016 Mar; 59(3):179-86. PubMed ID: 26855391
[TBL] [Abstract][Full Text] [Related]
17. Clinical criteria underestimate complete pathological response in rectal cancer treated with neoadjuvant chemoradiotherapy.
Smith FM; Wiland H; Mace A; Pai RK; Kalady MF
Dis Colon Rectum; 2014 Mar; 57(3):311-5. PubMed ID: 24509452
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of diffusion kurtosis and diffusivity from baseline staging MRI as predictive biomarkers for response to neoadjuvant chemoradiation in locally advanced rectal cancer.
Bates DDB; Mazaheri Y; Lobaugh S; Golia Pernicka JS; Paroder V; Shia J; Zheng J; Capanu M; Petkovska I; Gollub MJ
Abdom Radiol (NY); 2019 Nov; 44(11):3701-3708. PubMed ID: 31154482
[TBL] [Abstract][Full Text] [Related]
19. Rectal Cancer: Assessing Response to Neoadjuvant Therapy.
Maas M; Dijkhoff RAP; Beets-Tan R
Magn Reson Imaging Clin N Am; 2020 Feb; 28(1):117-126. PubMed ID: 31753231
[TBL] [Abstract][Full Text] [Related]
20. Prediction of pathologic staging with magnetic resonance imaging after preoperative chemoradiotherapy in rectal cancer: pooled analysis of KROG 10-01 and 11-02.
Lee JH; Jang HS; Kim JG; Lee MA; Kim DY; Kim TH; Oh JH; Park SC; Kim SY; Baek JY; Park HC; Kim HC; Nam TK; Chie EK; Jung JH; Oh ST
Radiother Oncol; 2014 Oct; 113(1):18-23. PubMed ID: 25245559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]